百合地黄汤经miRNA-144-3p改善抑郁小鼠前额叶SST中间神经元缺陷
该研究以慢性不可预见性温和应激构建抑郁小鼠模型,给予百合地黄汤标准汤剂干预。结果提示百合地黄汤可改善行为学表现,并逆转内侧前额叶SST阳性神经元中GABA合成与释放相关分子的降低,机制与下调miRNA-144-3p有关。
要点
- 百合地黄汤可改善抑郁模型小鼠行为学表现
- 其作用与逆转mPFC中SST阳性神经元缺陷相关
- 机制涉及miRNA-144-3p介导的GABA合成与释放
核心结论
- 百合地黄汤抗抑郁作用可能与调控miRNA-144-3p介导的GABA合成与释放、改善SST阳性神经元缺陷有关。
研究设计与样本
- 采用慢性不可预见性温和应激范式构建抑郁小鼠模型,给予百合地黄汤标准汤剂干预并进行行为学测试。
- 通过qRT-PCR和Western blot检测GABA相关miRNA/mRNA及GABA能亚型标志物。
- 采用荧光素酶报告基因、RNA免疫沉淀和RNA pull-down验证lncRNAs/miRNAs/GABA调控轴。
- 使用免疫荧光染色和RNA荧光原位杂交检测百合地黄汤给药后的相关变化。
主要发现
- 百合地黄汤在行为学测试中表现出较高疗效。
- 百合地黄汤通过增加lncRNA Neat1和Malat1表达、降低miRNA-144-3p和miRNA-15b-5p,改善抑郁状态下降低的GABA水平。
- 抑郁组小鼠mPFC组织中Sst mRNA和蛋白水平显著低于对照组,百合地黄汤可逆转这些变化。
- 慢性应激或治疗均未改变PV和VIP的mRNA及蛋白表达水平。
- 在mPFC的SST阳性神经元中,百合地黄汤使Gad-67、VGAT、GAT-3升高并降低miRNA-144-3p表达。
临床怎么用
- 百合地黄汤作为传统中药复方,在中国已多年联合常规西药用于抑郁症治疗。
- 本研究提示其抗抑郁作用可能与改善mPFC中SST阳性神经元功能有关,为临床联合用药提供机制参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Baihe Dihuang Decoction is a well-known traditional Chinese medicine prescription (Also known as Lilium Henryi Baker and Rehmannia Glutinosa Decoction, LBRD) composed of Lilium Henryi Baker bulb and raw juice from Rehmannia Glutinosa (Gaertn) DC with the curative efficacy of nourishing yin and clearing heat based on the Chinese herbal medicine theory. It has been used as routine medication in treating depression combined with conventional western medicine in China for years. AIM OF THE STUDY: LBRD can attenuates GABAergic deficits in the medial prefrontal cortex (mPFC) of depression. This study aimed to investigate the mechanism of antidepressive properties of LBRD in the prefrontal GABAergic interneuron subtypes, including parvalbumin (PV), somatostatin (SST), vasoactive intestinal peptide (VIP)-positive neuron. MATERIALS AND METHODS: In this project, chronic unpredicted mild stress paradigm was adopted to construct depression model. After treated with LBRD standard decoction and behaviors test, the level of GABA associated miRNA/mRNA and GABAergic subtype-specific markers were detected by qRT-PCR and Western blot. The lncRNAs/miRNAs/GABA regulatory axis was verified by luciferase reporter assay, RNA immunoprecipitation, RNA pull-down assay, and theses changes were measured in LBRD administration with the use of immunofluorescence staining and RNA-fluorescence in situ hybridization. RESULTS: In the current study, we found that LBRD exhibited high efficacy based on the results of behavioral tests. Meanwhile, LBRD also improved the reduced GABA levels in depression by increasing the expression of lncRNA Neat1 and Malat1, as well as decreasing miRNA-144-3p and miRNA-15b-5p. Moreover, the level of Sst mRNA and protein that were harvested from the mPFC tissues of depression group was significantly lower than those in the control mice. While, these changes can be reverted by LBRD standard decoction administration. Whereas, neither chronic stress nor treatment can change the level of PV and VIP mRNAs and protein expression. In the SST-positive neuron of mPFC tissues, treatment with LBRD standard decoction resulted in the elevation of Gad-67, VGAT, GAT-3 and a reduction of miRNA-144-3p expression. CONCLUSIONS: These findings suggested that LBRD antidepressant activities may be related to ameliorating the SST-positive neuron deficits via regulating the miRNA-144-3p mediated GABA synthesis and release.
引用
- Xue X, Pan J, Zhang H, et al. Baihe Dihuang (Lilium Henryi Baker and Rehmannia Glutinosa) decoction attenuates somatostatin interneurons deficits in prefrontal cortex of depression via miRNA-144-3p mediated GABA synthesis and release. J Ethnopharmacol. 2022. PMID: 35337919. doi:10.1016/j.jep.2022.115218
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。